Biological Perspectives: Drugs used for cognitive symptoms of alzheimer's disease

Perspectives in Psychiatric Care

Volumn 37, Issue 1, 2001, Pages 31-34

  Keltner, Norman L ^a   Zielinski, Angela L ^b   Hardin, M Sloan ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Department of Pathology Brookwood Medical Center   (United States)

Author keywords

Alzheimer's disease; Donepezil; Galantamine; Rivastigmine; Tacrine

Indexed keywords

CARBAMIC ACID DERIVATIVE; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; INDAN DERIVATIVE; PIPERIDINE DERIVATIVE; RIVASTIGMINE; TACRINE;

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; HUMAN;

AGED; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; COGNITION DISORDERS; GALANTAMINE; HUMANS; INDANS; PHENYLCARBAMATES; PIPERIDINES; TACRINE;

EID: 16544377327     PISSN: 00315990     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1744-6163.2001.tb00614.x     Document Type: Review

References (13)

1. Alagiakrishnan, K., Wong, W., & Blanchette, P.L. (2000). Use of donepezil in elderly patients with Alzheimer's disease - A Hawaii based study. Hawaii Medical Journal, 59, 57-59.
2. Geldmacher, D.S. (1997). Donepezil (Aricept) therapy for Alzheimer's disease. Comprehensive Therapy, 23, 492-493.
3. Keltner, N.L. (1994). Tacrine: A pharmacological approach to Alzheimer's disease. Journal of Psychosocial Nursing and Mental Health Services, 32(3), 37-39.
4. Keltner, N.L., & Folks, D.G. (2001). Psychotropic drugs (3rd ed.). Philadelphia: Harcourt Health Sciences.
5. Nordberg, A., & Svensson, A. (1998). Cholinesterase inhibitors in the treatment of Alzheimer's disease. Drug Experience, 19, 465-480.
6. Purves, D., Augustine, G.J., Fitzpatrick, D., Katz, L.C., LaMantia, A.S., & McNamara, J.O. (1997). Neuroscience. Sunderland, MA: Sinauer Associates.
7. Raskind, M.A., Peskind, E.R., Wessel, T., & Yuan, W. (2000). Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. Neurology, 54, 2261-2268.
8. Rogers, S.L., Doody, R.S., Mohs, R.C., & Friedhoff, L.T. (1998). Donepezil improves cognition and global function in Alzheimer's disease. Archives of Internal Medicine, 158, 1021-1031.
9. Ross, J.S., & Shua-Haim, J.R. (1998). Aricept-induced nightmares in Alzheimer's disease: 2 case reports (letter). Journal of the American Geriatric Society, 46, 119-120.
10. Samuels, S.C., & Davis, K.L. (1997). A risk-benefit assessment of tacrine in the treatment of Alzheimer's disease. Drug Safety, 16, 66-77.
11. Summers, W.K., Majovski, L.V., Marsh, G.M., Tachiki, K., & Kling, A. (1986). Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. New England Journal of Medicine, 315, 1241-1245.
12. Tariot, P.N., Solomon, P.R., Morris, J.C., Kershaw, P., Lilienfeld, S., & Ding, C. (2000). A 5-month, randomized, placebo-controlled trial of galantamine in AD. Neurology, 54, 2269-2276.
13. Terpstra, T., & Terpstra, T. (1998). Treating Alzheimer's disease with cholinergic drugs, Part I. Nurse Practitioner, 23, 90-102.